該当箇所へ

ウェビナー動画:Crohn's & Colitis Foundation(CCF)、小児クローン病における予測バイオマーカーパネルの開発に向けて

CCFは、Genedata Profiler®の高度なデータ解析機能を活用し、小児クローン病における予測バイオマーカーの探索を行っています。本ウェビナーでは、CCFのVPであるAndres Hurtado-Lorenzo氏が登壇し、CCFが取った段階的なアプローチと、その結果として得られた洞察について紹介しています。

Predicting potential future complications and response to treatment in pediatric Crohn’s disease patients using biomarkers will help provide optimal care and improve healthcare outcomes.

Learn how Genedata Profiler allow you to unlock insights from high-dimensional multi-omics data to identify such biomarkers.

In this webinar, the non-profit organization dedicated to curing IBD (Inflammatory Bowel Disease) shares its latest progress in its ongoing research and development activities. During his presentation, Dr. Andrés Hurtado-Lorenzo, VP of Translational Research and IBD Ventures at the Crohn’s & Colitis Foundation, will present:

  • How Genedata Profiler enables advanced analytical approaches such as machine learning to discover prognostic gene and protein expression signatures, and  
  • Some results generated using a custom biomarker panel that was developed from these approaches, elucidating its utility as a clinical tool for early prognosis of disease course in pediatric Crohn’s disease

Who should watch it?

Biopharma and biotech professionals working in translational research looking to identify biomarkers through analyzing multi-omic data from different drug development stages to guide the treatment of patients with complex diseases. 

Speaker: Dr. Andrés Hurtado-Lorenzo, Vice President of Translational Research and IBD Ventures at the Crohn’s & Colitis Foundation


資料をリクエスト

本フォームを送信することで、Genedata プライバシーポリシー に従い個人情報が収集・利用されることへ同意します。